FDA Inspection 1059418 — Haupt Pharma Latina Srl

Haupt Pharma Latina Srl — FEI 3007687501

The FDA completed an inspection of Haupt Pharma Latina Srl on June 28, 2018 in Latina. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 28, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Latina (Italy)

Citations

IDCFRDescription
104921 CFR 211.22(a)Approve or reject components, products
111121 CFR 211.25(a)Training , Education , Experience overall
145121 CFR 211.113(b)Procedures for sterile drug products
356521 CFR 211.58Buildings not maintained in good state of repair
360321 CFR 211.160(b)Scientifically sound laboratory controls